Tirzepatide: Tirzepatide, a dual GIP/GLP-1 agonist, represents a newer generation of metabolic peptides with potent weight loss effects through combined appetite suppression and metabolic enhancement
The effectiveness of semaglutide does not require reaching the maximum dose quickly
doi: 10.3389/fbioe.2024.1490276 Received 02 September 2024 Accepted 02 December 2024 Published 10 January 2025 Volume 12 - 2024 Edited by Artur Ribeiro, University of Minho, Portugal Reviewed by Dave Siak-Wei Ow, Bioprocessing Technology Institute (ASTAR), Singapore Carla Silva, University of Minho, Portugal Updates Copyright 2025 Felix, Waerner, Lakatos, Reisinger, Fischer and Garidel
BPC 157 has beneficial effects and thus leads to stomach cytoprotection organoprotection of the whole gastrointestinal tract, including both prophylactic and therapeutic effects for pre-existing lesions in individuals with the most complex disturbances, such as internal and external fistulas, or anastomosis complicated with severe colitis (indicated as +1)
